Denmark· DK-28105557115
Uptravi
A selexipag product containing selexipag, registered in Denmark by Janssen-Cilag International NV. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Selexipag is registered in 13 of 19 countries.
Countries holding a registration under ATC B01AC27 (selexipag), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Selexipag · ATC B01AC27
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of selexipag costs, country by country.
Normalised to the WHO defined daily dose (1.8 mg), the median price runs from $809.99 in Switzerland to $1232.99 in Italy — a ×1.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Selexipag · price per daily dose (1.8 mg)
USD · FX 28 Sept 2026
- IT Italy$1232.99
- CH Switzerland$809.99
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Selexipag
- Manufacturer
- Janssen-Cilag International NV
- Country
- Denmark (DK)
- ATC code
- B01AC27
- ATC class
- Selexipag
- Defined daily dose
- 1.8 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105557115
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
237 interactions on record for selexipag.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Selexipag · interactions on record
237 records
- 1 severe
- 232 moderate
- 4 minor
Most severe, free to view
- GemfibrozilC10AB04severe
- PapaverineA03AD01moderate
- MannitolA06AD16moderate
- GlycerolA06AX01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AC27
Selexipag, as other registers publish it.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
- DenmarkSelexipag "Accord"Accord Healthcare B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf9047af-392b-40e2-b3e1-57db3b4de6ea GET /v1/drugs/bf9047af-392b-40e2-b3e1-57db3b4de6ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "800 mikrogram",
"auth_role": "MOD",
"dk_drugid": "28105557115",
"substance": "Selexipag",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42502"
}See everything about selexipag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.